---
title: "Molindone - Schizophrenia"
sidebar: mydoc_sidebar
permalink: db01618-mesh-d012559-1.html
toc: false 
---


Path ID: `DB01618_MESH_D012559_1`
{% include image.html url="images/db01618-mesh-d012559-1.png" file="db01618-mesh-d012559-1.png" alt="db01618-mesh-d012559-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| DB:DB01618 | Molindone | Drug |
| UniProt:P14416 | Dopamine D2 receptor | Protein |
| GO:0061527 | Dopamine secretion, neurotransmission | BiologicalProcess |
| MESH:D004298 | Dopamine | ChemicalSubstance |
| HP:0000738 | Hallucinations | PhenotypicFeature |
| MESH:D012559 | Schizophrenia | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Molindone | DECREASES ACTIVITY OF | Dopamine D2 Receptor |
| Dopamine D2 Receptor | MOLECULARLY INTERACTS WITH | Dopamine |
| Dopamine | PARTICIPATES IN | Dopamine Secretion, Neurotransmission |
| Dopamine Secretion, Neurotransmission | POSITIVELY CORRELATED WITH | Hallucinations |
| Hallucinations | MANIFESTATION OF | Schizophrenia |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB01618](https://go.drugbank.com/drugs/DB01618)
  - [https://en.wikipedia.org/wiki/Schizophrenia#Positive_symptoms](https://en.wikipedia.org/wiki/Schizophrenia#Positive_symptoms)
  - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996210/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996210/)
